Back to search

Article

Androgen receptor activity promotes resistance to BRAF-targeted melanoma therapy

2020-08-17

Abstract excerpt

<title>Abstract</title> <p>Treatment with molecularly-targeted therapy has revolutionized cancer care, including BRAF/MEK-targeted melanoma therapy. However responses are heterogenous and frequently not long-lasting. Novel strategies to target resistance are needed. We studied a cohort of patients with resectable metastatic melanoma treated with neoadjuvant BRAF/MEK-targeted therapy (n=52) and noted a strong sexu...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
46f93f44-13c8-5482-bf47-225132b6593d
DOI
10.21203/rs.3.rs-58480/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Androgen receptor activity promotes resistance to BRAF-targeted melanoma therapyDOI 10.21203/rs.3.rs-58480/v1
Select a neighboring publication to make it the new centre.